UBS AG is preparing trigger autocallable contingent Yield notes priced at $1,000.00 each and linked to the Solactive U.S. Large Cap Volatility Navigator Index, with Maturity on or about October 3, 2031. Investors face unsecured exposure, no FDIC insurance and market values affected by several underlying and financial factors.
Key Highlights
- UBS Securities LLC is due a $2.50 Underwriting discount for each Note sold.
- A Secondary Market is intended but not guaranteed, and UBS affiliates may stop providing one at any time.
- The Notes are unsubordinated, unsecured Debt obligations of UBS AG and are not bank deposits or insured by the FDIC or any other governmental agency.
$1,000 Notes Linked to Volatility Index
The public price is $1,000 per Note, while UBS Securities LLC is to receive $2.50 per Note as underwriting compensation. Proceeds to UBS AG are $997.50 per Note. UBS Securities LLC may also pay an unaffiliated dealer a $20.00 Marketing fee per Note, with that amount deducted from sums remitted to UBS.
Secondary-Market Pricing Carries Multiple Variables
Before maturity, the Market Price may also respond to the index and its constituents, volatility, remaining term, interest rates, geopolitical and economic conditions, UBS creditworthiness and bid-ask spreads.
FAQs
Q: What is the issue price of UBS AG’s trigger autocallable notes?
A: UBS AG’s trigger autocallable contingent yield notes carry a public issue price of $1,000 per Note.
Q: Are UBS AG’s trigger autocallable notes insured?
A: The Notes are unsecured obligations of UBS AG, not bank deposits, and are not insured by the FDIC or any other governmental agency.
Q: What FINRA rule applies to the UBS AG note offering?
A: The article does not state which FINRA rule applies to the UBS AG note offering. It states only that UBS Securities LLC will receive underwriting compensation and that proceeds will go to UBS AG.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.